Skip to contentS
SI-BONE, Inc.
S
SIBNSI-BONE, Inc. Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$38.86M$38.86Mderived+21.6% vs Q4 2022 Net Income-$10.98M-$10.98MderivedN/M vs Q4 2022 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SI-BONE, Inc. · CIK 1459839 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$28,676,000+6.7% Operating Incomederived-$12,506,000N/M Operating Cash Flowderived-$2,297,000N/M Free Cash Flowderived-$3,390,000N/M Margins · derivedGross margin73.8%−10.3 pt vs Q4 2022
Operating margin-32.2%+3.2 pt vs Q4 2022
Net margin-28.3%+6.7 pt vs Q4 2022
ended Dec 31, 2023 · filed Feb 27, 2024 · 58 d after period end